Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 30 years and older, ECDC multi-country study – second update

European Centre for Disease Prevention and Control, ECDC COVID-19 vaccine effectiveness hospital study participants, Nassera Aouali, F. Berthet, P. Braquet, G. Fagherazzi, M. Simon

Research output: Book/ReportCommissioned reportpeer-review

37 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 30 years and older, ECDC multi-country study – second update'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology